Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia
[ X ]
Tarih
2006
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
John Wiley & Sons Inc
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 27-31, 2006 -- Boston, MA
Anahtar Kelimeler
[No Keyword]
Kaynak
Hepatology
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
44
Sayı
4
